Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,400
Closed -$7.1K 15310
2025
Q1
$7.1K Buy
1,400
+700
+100% +$3.98K ﹤0.01% 13710
2024
Q4
$4.12K Buy
+700
New +$4.59K ﹤0.01% 13951
2024
Q3
Sell
-100
Closed -$726 15345
2024
Q2
$726 Sell
100
-700
-88% -$5.07K ﹤0.01% 13929
2024
Q1
$6.54K Buy
800
+100
+14% +$801 ﹤0.01% 13661
2023
Q4
$4.82K Sell
700
-1,800
-72% -$11K ﹤0.01% 13480
2023
Q3
$12.5K Buy
2,500
+1,200
+92% +$6.41K ﹤0.01% 12961
2023
Q2
$6.24K Sell
1,300
-400
-24% -$1.59K ﹤0.01% 13438
2023
Q1
$6.53K Buy
1,700
+1,000
+143% +$4.07K ﹤0.01% 13798
2022
Q4
$2.63K Buy
+700
New +$2.67K ﹤0.01% 14308

Other funds holding VTEX

Citadel Advisors's VTEX Position: Q2 2026 in Review

Citadel Advisors increased its VTEX (VTEX) stake by 223% in Q2 2026, buying an estimated $3.68M and bringing the position to 1,397,368 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #4526.

Citadel Advisors first reported a position in VTEX in Q3 2021 and has held it in 20 quarters since. 109 funds tracked by Wall St. Rank hold VTEX as of Q2 2026.

  • Citadel Advisors held 1,397,368 shares of VTEX worth $5.59M as of Q2 2026.
  • Citadel Advisors bought 964,682 VTEX shares in Q2 2026, an estimated $3.68M.
  • VTEX made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4526 holding.
  • Citadel Advisors first reported a position in VTEX in Q3 2021 and has held it in 20 quarters since.
  • 109 funds tracked by Wall St. Rank held VTEX as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.